This compound is a pharmaceutical intermediate used in the production of antiviral prodrugs. It features a purine nucleoside core linked to a valine ester, contributing to its role in active pharmaceutical ingredient synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Valganciclovir hydrochloride
pharmaceutical raw material
Valganciclovir
pharmaceutical raw material
L-Alanine, N,N′-[[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphinylidene]bis-, 1,1′-bis(1-methylethyl) ester
pharmaceutical raw material
Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide
pharmaceutical raw material
Perindoprilat isopropyl ester
pharmaceutical raw material
Amlodipine maleate
pharmaceutical raw material
4-epi-Dolutegravir
pharmaceutical raw material
[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxymethoxy]-3-hydroxypropyl] (2R)-2-amino-3-methylbutanoate
DVCUGHHGLKCBMT-QVDQXJPCSA-N
CC(C)[C@H](C(=O)OCC(CO)OCOCN1C=NC2=C1N=C(NC2=O)N)N
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.